Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF PROFIT AND LOSS AND OTHER COMPREHENSIVE LOSS

v3.22.2
CONSOLIDATED STATEMENTS OF PROFIT AND LOSS AND OTHER COMPREHENSIVE LOSS - USD ($)
 12 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Disclosure of disaggregation of revenue from contracts with customers [line items]    
Total Revenue, Net $ 0 $ 123,820
Cost of revenue   133,254
Gross profit   (9,434)
Operating expenses:    
Sales and Marketing 13,818 57,203
Research & Development 433,743 120,221
General and Administrative 1,286,118 457,680
Total operating expenses 1,733,679 635,104
Operating loss (1,733,679) (644,538)
Other income (expense):    
Interest expense, net (15,438) (28,643)
Other income (expense), net (753) 266
Total other income (expense) (16,191) (28,377)
Loss before income taxes (1,749,870) (672,915)
Net loss (1,749,870) (672,915)
Net loss attributable to non-controlling interest (41,043) (21,931)
Net loss attributable to Virax (1,708,827) (650,984)
Other comprehensive income (loss)    
Foreign currency adjustment (965) 3,701
Comprehensive loss (1,748,905) (676,616)
Comprehensive income, attributable to non-controlling interests (78,065) (30,202)
Comprehensive loss attributable to Virax $ (1,670,840) $ (646,414)
Class A    
Basic and diluted weighted average shares outstanding    
Basic and diluted weighted average shares outstanding 2,550,773 1,581,443
Basic and diluted net loss per share    
Basic and diluted net loss per share $ (0.67) $ (0.41)
Class B    
Basic and diluted weighted average shares outstanding    
Basic and diluted weighted average shares outstanding 7,012,487 823,399
Basic and diluted net loss per share    
Basic and diluted net loss per share $ (0.24) $ (0.79)
ViraxClear and ViraxCare Revenue    
Disclosure of disaggregation of revenue from contracts with customers [line items]    
Total Revenue, Net   $ 104,820
Consulting Revenues    
Disclosure of disaggregation of revenue from contracts with customers [line items]    
Total Revenue, Net   $ 19,000